Results 101 to 110 of about 3,533,009 (320)

The Dynamics of the Forest Graph Operator

open access: yes, 2016
In 1966, Cummins introduced the "tree graph": the tree graph $\mathbf{T}(G)$ of a graph $G$ (possibly infinite) has all its spanning trees as vertices, and distinct such trees correspond to adjacent vertices if they differ in just one edge, i.e., two ...
Dara, Suresh   +4 more
core   +1 more source

Chemoresistome mapping in individual breast cancer patients unravels diversity in dynamic transcriptional adaptation

open access: yesMolecular Oncology, EarlyView.
This study used longitudinal transcriptomics and gene‐pattern classification to uncover patient‐specific mechanisms of chemotherapy resistance in breast cancer. Findings reveal preexisting drug‐tolerant states in primary tumors and diverse gene rewiring patterns across patients, converging on a few dysregulated functional modules. Despite receiving the
Maya Dadiani   +14 more
wiley   +1 more source

The Orchard crossing number of an abstract graph

open access: yes, 2009
We introduce the Orchard crossing number, which is defined in a similar way to the well-known rectilinear crossing number. We compute the Orchard crossing number for some simple families of graphs. We also prove some properties of this crossing number.
Abstract Graph, David Garber, Elie Feder
core   +2 more sources

IPC: A Benchmark Data Set for Learning with Graph-Structured Data [PDF]

open access: yes, 2019
Benchmark data sets are an indispensable ingredient of the evaluation of graph-based machine learning methods. We release a new data set, compiled from International Planning Competitions (IPC), for benchmarking graph classification, regression, and ...
Chen, Jie   +4 more
core   +1 more source

Evaluation of KRAS and NRAS mutations in metastatic colorectal cancer: an 8‐year study of 10 754 patients in Turkey

open access: yesMolecular Oncology, EarlyView.
This nationwide study evaluated KRAS and NRAS mutations in 10 754 Turkish patients with metastatic colorectal cancer. The results revealed a mutation frequency of 51.1%, with 46.6% having KRAS mutations, 4.5% having NRAS mutations, and 48.5% being wild‐type for both.
Gozde Kavgaci   +6 more
wiley   +1 more source

Graph enumeration and random graphs

open access: yes, 2023
In this thesis we use analytic combinatorics to deal with two related problems: graph enumeration and random graphs from constrained classes of graphs. We are interested in drawing a general picture of some graph families by determining, first, how many elements are there of a given possible size (graph enumeration), and secondly, what is the typical ...
openaire   +4 more sources

Factors associated with the risk of HIV infection among HIV-exposed infants in Malawi: 2013–2020

open access: yesBMJ Paediatrics Open, 2022
Janne Estill   +6 more
doaj   +1 more source

The anticancer effect of the HDAC inhibitor belinostat is enhanced by inhibitors of Bcl‐xL or Mcl‐1 in ovarian cancer

open access: yesMolecular Oncology, EarlyView.
The pan‐HDAC inhibitor belinostat increases the expression of the pro‐apoptotic proteins Bim, Puma, and Noxa and induces apoptosis in ovarian cancer cell lines and patient‐derived tumor organoids when used at high concentrations. Moreover, inhibiting the anti‐apoptotic proteins Bcl‐xL or Mcl‐1 sensitizes these preclinical models to the cytotoxic effect
Cécilia Thomine   +10 more
wiley   +1 more source

An in-depth statistical analysis of the COVID-19 pandemic’s initial spread in the WHO African region

open access: yesBMJ Global Health, 2022
Cristina Barroso Hofer   +19 more
doaj   +1 more source

Dose‐dependent induction of epithelial‐mesenchymal transition in 3D melanoma models by non‐thermal plasma treatment

open access: yesMolecular Oncology, EarlyView.
Non‐thermal plasma treatment of melanoma cells induced epithelial‐mesenchymal transition (EMT) in a dose‐dependent fashion. This report highlights the critical need to further investigate potential adverse effects of non‐thermal plasma for cancer therapy and to optimize treatment parameters for clinical translation. Despite the promising results of non‐
Eline Biscop   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy